Highlights and Quick Summary
- Cash and Short Term Investments for the quarter ending December 31, 2022 was $10.6 Million (a -36.24% decrease compared to previous quarter)
- Year-over-year quarterly Cash and Short Term Investments increased by 22.26%
- Annual Cash and Short Term Investments for 2022 was $4.08 Million (a 0.0% decrease from previous year)
- Annual Cash and Short Term Investments for 2022 was $4.08 Million (a -79.4% decrease from previous year)
- Annual Cash and Short Term Investments for 2021 was $19.8 Million (a 0.08% increase from previous year)
Visit stockrow.com/BNTC
for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow
statement with 10 years of data, and state-of-the-art screener.
Historical Cash and Short Term Investments of Benitec Biopharma Limited
Most recent Cash and Short Term Investmentsof BNTC including historical data for past 10 years.Interactive Chart of Cash and Short Term Investments of Benitec Biopharma Limited
Benitec Biopharma Limited Cash and Short Term Investments for the past 10 Years (both Annual and Quarterly)
(All values are in $ million)
Year | Q1 | Q2 | Q3 | Q4 | Fiscal Year |
---|---|---|---|---|---|
2022 | $10.55 | $16.55 | $4.08 | $8.63 | $4.08 |
2021 | $12.33 | $15.73 | $19.78 | $11.99 | $19.78 |
2020 | $14.01 | $7.45 | $9.8 | $11.4 | $9.8 |
2019 | – | – | – | $13.45 | $15.72 |
2018 | – | – | – | – | $12.47 |
2017 | – | – | – | $11.61 | $13.1 |
2016 | – | $10.15 | $13.27 | $14.35 | $13.28 |
2015 | – | – | $16.39 | $18.24 | $18.24 |
2014 | – | – | $22.95 | $28.79 | $28.8 |
2013 | $1.63 | – | – | – | $1.63 |
Business Profile of Benitec Biopharma Limited
Sector: Healthcare
Industry: Biotechnology